These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9604995)

  • 1. The significance of anti-sialyl-Tn antibodies in patients with colorectal and breast cancer.
    Coomber DW; Hawkins NJ; Dalley D; Ward RL
    Neoplasma; 1998; 45(1):12-6. PubMed ID: 9604995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.
    O'Boyle KP; Zamore R; Adluri S; Cohen A; Kemeny N; Welt S; Lloyd KO; Oettgen HF; Old LJ; Livingston PO
    Cancer Res; 1992 Oct; 52(20):5663-7. PubMed ID: 1394190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation of serum anti-(GalNAc beta) and -para-Forssman disaccharide IgG levels to the progression and histological grading of gastrointestinal cancer.
    Smorodin EP; Kurtenkov OA; Sergeyev BL; Chuzmarov VI; Afanasyev VP
    Exp Oncol; 2007 Mar; 29(1):61-6. PubMed ID: 17431391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
    Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J
    Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine.
    MacLean GD; Reddish MA; Koganty RR; Longenecker BM
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):59-68. PubMed ID: 8859725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.
    Hanski C; Hanski ML; Zimmer T; Ogorek D; Devine P; Riecken EO
    Cancer Res; 1995 Feb; 55(4):928-33. PubMed ID: 7850810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum sialyl-Tn antigen in colorectal cancer and its relationship to prognosis].
    Yamaguchi A; Tukioka Y; Fushida S; Kurosaka Y; Kanno M; Yonemura Y; Miwa K; Miyazaki I
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):349-53. PubMed ID: 1543361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.
    Longenecker BM; Reddish M; Koganty R; MacLean GD
    Adv Exp Med Biol; 1994; 353():105-24. PubMed ID: 7527178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.
    Freire T; Lo-Man R; Piller F; Piller V; Leclerc C; Bay S
    Glycobiology; 2006 May; 16(5):390-401. PubMed ID: 16449349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An O-acetylated sialyl-Tn is involved in ovarian cancer-associated antigenicity.
    Toba S; Tenno M; Kurosaka A
    Biochem Biophys Res Commun; 2000 May; 271(2):281-6. PubMed ID: 10799288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
    Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
    J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Kurosaki N; Ayabe H; Arisawa K
    Cancer Detect Prev; 2001; 25(3):299-308. PubMed ID: 11425272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific detection of sialyl Lewis X determinant carried on the mucin GlcNAcbeta1-->6GalNAcalpha core structure as a tumor-associated antigen.
    Kumamoto K; Mitsuoka C; Izawa M; Kimura N; Otsubo N; Ishida H; Kiso M; Yamada T; Hirohashi S; Kannagi R
    Biochem Biophys Res Commun; 1998 Jun; 247(2):514-7. PubMed ID: 9642161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Tn human monoclonal antibodies generated following active immunization with partially desialylated ovine submaxillary mucin.
    O'Boyle KP; Wright K
    Hum Antibodies Hybridomas; 1994; 5(1-2):25-31. PubMed ID: 7532023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma.
    Imai J; Ghazizadeh M; Naito Z; Asano G
    Anticancer Res; 2001; 21(2B):1327-34. PubMed ID: 11396208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-pathological characteristics of colorectal cancer and serum anti-p53 antibodies.
    Bielicki D; Karbowniczek M; Sulzyc-Bielicka V; Kładny J; Boer C; Marlicz K; Domagała W
    Pol J Pathol; 1999; 50(2):77-81. PubMed ID: 10481530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in prognosis of colorectal cancer patients based on the expression of sialyl Lewisa, sialyl Lewisx and sialyl Tn antigens in serum and tumor tissue.
    Akamine S; Nakagoe T; Sawai T; Tsuji T; Tanaka K; Hidaka S; Shibasaki S; Nanashima A; Yamaguchi H; Nagayasu T; Yasutake T
    Anticancer Res; 2004; 24(4):2541-6. PubMed ID: 15330211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women.
    Frenkel K; Karkoszka J; Glassman T; Dubin N; Toniolo P; Taioli E; Mooney LA; Kato I
    Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):49-57. PubMed ID: 9456243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
    Ragupathi G; Howard L; Cappello S; Koganty RR; Qiu D; Longenecker BM; Reddish MA; Lloyd KO; Livingston PO
    Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.